Oberland Capital Revenue and Competitors

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Oberland Capital's estimated annual revenue is currently $4M per year.(i)
  • Oberland Capital's estimated revenue per employee is $158,900

Employee Data

  • Oberland Capital has 25 Employees.(i)
  • Oberland Capital grew their employee count by 0% last year.

Oberland Capital's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VPReveal Email/Phone
3
VPReveal Email/Phone
4
SVPReveal Email/Phone
5
DirectorReveal Email/Phone
6
Managing Director EuropeReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
General Counsel and Chief Compliance OfficerReveal Email/Phone
9
Director Business Development and Investor RelationsReveal Email/Phone
10
Managing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M408%N/AN/A
#2
$38.8M15911%N/AN/A
#3
$58.2M2335%N/AN/A
#4
$37.1M152-7%N/AN/A
#5
$3.5M220%N/AN/A
#6
$6.5M36-3%N/AN/A
#7
$17.9M798%N/AN/A
#8
$282.4M8700%N/AN/A
#9
$6M205%$73MN/A
#10
$46.2M1852%N/AN/A
Add Company

What Is Oberland Capital?

Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investment in debt and equity securities. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for our transaction partners. For more information please visit www.oberlandcapital.com.

keywords:N/A

N/A

Total Funding

25

Number of Employees

$4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oberland Capital News

2022-04-06 - Curis Announces FDA Partial Clinical Hold for TakeAim ...

In connection with its agreement with Oberland Capital, Curis faces risks relating to the transfer and encumbrance of certain royalty and...

2022-03-30 - Centessa Pharmaceuticals Reports Fourth Quarter and 2021 ...

Entered into financing agreement with funds managed by Oberland Capital Management LLC (“Oberland Capital”) and received initial $75 million...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M25-4%N/A
#2
$2.8M254%N/A
#3
$1.8M254%$48.9M
#4
$1.8M25-22%$1.6M
#5
$1.8M25-29%$67M